Now to the new Food and Drug Administration Commissioner Dr. Marty McCarrie.

And a wide-ranging conversation I had with him earlier today as part of Semaphore's World Economy Summit.

Among the many topics we discussed, Miffa Pristone, and what plans the FDA may have in store for medication, abortion,

which accounted for 63% of U.S. abortions in 2023.

Many conservatives want the FDA to impose tighter restrictions on Mitha-Pristone and Misoprostol,

which can be delivered by mail. Here is some of what Dr. McCarrie said.

On Miphrastone, do you expect to take action further restricting the pill?

I have no plans to take action on Mifiphrus stone.

Could that be changed over the course of your tenure, given the pressure that I know has come from a lot of the political forces of play on this?

So, look, I believe as a scientist, you've got to evolve as the data comes in, and as you may know, there is an ongoing set of data that is coming in to FDA

on Mifapristone so if the data suggests something or tells us that there's a real signal

then I you know we can't promise we're not going to act on that data that we have not yet seen

but if that new data contradicts the decades of data that said that it's overwhelmingly

safe and effective, you would go with the new data rather than the precedent of decades of data?

Well, it's very hypothetical, right?

Because you're talking about the strength of the data, the safety of the data, the reliability

of the data.

So it's very hypothetical what you're asking, but in general, I'm a data guy.

Commissioner McCary also seemed to agree today that the federal government should reverse itself

and no longer recommend the COVID booster for children. HHS secretary Robert F. Kennedy Jr.

is reportedly considering that.

Previous scientific panels have found it safe and beneficial to prevent kids from getting seriously ill,

...